Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. DrugBank 薬物名(臨床試験情報から抽出) KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Artesunate 1件: Artesunate1件: Artesunate 💬--6件: 18, 53, 66, 96, 215, 271 💬
2 Baclofen 2件: Baclofen; Kemstro1件: Baclofen 💬2件: GABBR1,
GABBR2 💬
7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬8件: 2, 10, 13, 18, 65, 70, 149, 206 💬
3 Bupropion 2件: Bupropion; Bupropion Hydrochloride1件: Bupropion 💬2件: SLC6A2,
SLC6A3 💬
7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬5件: 8, 18, 21, 96, 171 💬
4 Butylphthalide 1件: Butylphthalide---4件: 2, 6, 18, 22 💬
5 Calcitriol 1件: Calcitriol1件: Calcitriol 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬9件: 18, 37, 46, 49, 66, 96, 158, 235, 326 💬
6 Carbonate ion 1件: Carbonate---12件: 2, 13, 17, 18, 19, 46, 53, 75, 96, 127, 235, 299 💬
7 Citalopram 1件: Citalopram1件: Citalopram 💬1件: SLC6A4 💬2件: Serotonergic synapse, Synaptic vesicle cycle 💬7件: 6, 8, 13, 18, 46, 98, 127 💬
8 CTI-1601 1件: CTI-1601---1件: 18 💬
9 Deferiprone 2件: Deferiprone; Ferriprox1件: Deferiprone 💬--6件: 2, 6, 18, 120, 122, 233 💬
10 Erythropoietin 4件: Epoetin alfa; Epoetin beta; Erythropoietin; NeoRecormon---10件: 2, 6, 13, 18, 22, 46, 47, 70, 95, 96 💬
11 Etravirine 3件: ETRAVIRINA; Etravirine; INTELENCE1件: Etravirine 💬--1件: 18 💬
12 Flumazenil 1件: Flumazenil1件: Flumazenil 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬
7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬5件: 6, 13, 17, 18, 206 💬
13 Ginkgo biloba 3件: Ginkgo; Ginkgo biloba; Tanakan---5件: 6, 13, 18, 47, 90 💬
14 Idebenone 2件: Idebenone; Raxone1件: Idebenone 💬--6件: 6, 8, 13, 18, 113, 302 💬
15 Interferon Gamma 1件: Interferon Gamma---8件: 18, 65, 85, 107, 228, 299, 301, 326 💬
16 Interferon gamma-1b 2件: ACTIMMUNE; Interferon Gamma-1B1件: Interferon gamma-1b 💬2件: IFNGR1,
IFNGR2 💬
18件: Chagas disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬7件: 18, 65, 85, 228, 299, 301, 326 💬
17 Iron 1件: Iron---6件: 18, 96, 97, 238, 254, 284 💬
18 Lenograstim 2件: G-CSF; LENOGRASTIM1件: Lenograstim 💬1件: CSF3R 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬7件: 2, 13, 16, 18, 19, 57, 65 💬
19 Lithium carbonate 2件: Lithium; LITHIUM CARBONATE1件: Lithium carbonate 💬--5件: 2, 13, 17, 18, 127 💬
20 Methylprednisolone 4件: Medrol; Methylprednisolon; Methylprednisolone; Methylprednisolone acetate1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬46件: 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬
21 Nicotinamide 3件: Multivitamin; Niacinamide; Nicotinamide1件: Niacinamide 💬--10件: 2, 5, 6, 18, 49, 67, 97, 107, 162, 191 💬
22 Nicotinamide riboside 1件: Nicotinamide Riboside---5件: 2, 6, 18, 97, 191 💬
23 Omaveloxolone 1件: Omaveloxolone1件: Omaveloxolone 💬1件: NFE2L2 💬7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
24 Resveratrol 1件: Resveratrol---6件: 2, 8, 18, 89, 97, 113 💬
25 Riluzole 2件: Rilutek; Riluzole1件: Riluzole 💬14件: GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬9件: 2, 3, 5, 8, 13, 17, 18, 203, 206 💬
26 Rosuvastatin 3件: Crestor; Rosuvastatin; Rosuvastatin calcium1件: Rosuvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬11件: 6, 18, 46, 49, 51, 56, 79, 96, 97, 271, 299 💬
27 TAK-831 1件: TAK-831---1件: 18 💬
28 Trehalose 2件: Cabaletta; Trehalose---4件: 2, 6, 18, 113 💬
29 Ubidecarenone 3件: Coenzyme Q-10; Coenzyme Q10; CoQ101件: Ubidecarenone 💬--12件: 2, 5, 6, 8, 10, 18, 46, 57, 86, 113, 214, 215 💬
30 Varenicline 2件: Champix; VARENICLINE1件: Varenicline 💬2件: CHRNA4,
CHRNB2 💬
4件: Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction 💬3件: 6, 18, 53 💬
31 Vatiquinone 1件: VATIQUINONE1件: Vatiquinone 💬--2件: 18, 21 💬